catalpol has been researched along with Insulin Resistance in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattamisra, SK; Candasamy, M; Ching, TS; Elhassan, SAM; Heng, YK | 1 |
| Abdul Majeed, AB; Bhattamisra, SK; Candasamy, M; Md, S; Tan, SC; Yap, KH; Yee, GS | 1 |
| Jin, Y; Liu, K; Liu, Q; Liu, Z; Meng, Q; Sun, H; Wang, C; Yan, J | 1 |
| Fan, S; Hassan, HM; Jiang, Z; Sun, L; Wang, L; Wang, T; Xu, D; Zhang, L; Zhao, G; Zhou, Z | 1 |
| Huang, K; Li, F; Ma, S; Xu, G; Xu, H; Yuan, M; Zhou, J | 1 |
5 other study(ies) available for catalpol and Insulin Resistance
| Article | Year |
|---|---|
Effect of madecassoside and catalpol in amelioration of insulin sensitivity in pancreatic (INS-1E) β-cell line.
Topics: Animals; Cell Line; Glucose; Insulin; Insulin Resistance; Insulin-Secreting Cells; Iridoid Glucosides; Rats; Triterpenes | 2021 |
Catalpol Ameliorates Insulin Sensitivity and Mitochondrial Respiration in Skeletal Muscle of Type-2 Diabetic Mice Through Insulin Signaling Pathway and AMPK/SIRT1/PGC-1α/PPAR-γ Activation.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Insulin; Insulin Resistance; Iridoid Glucosides; Mice, Inbred NOD; Mitochondrial Diseases; Muscle, Skeletal; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Protein Kinases; Signal Transduction; Sirtuin 1 | 2020 |
Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin Resistance; Iridoid Glucosides; Liver; Male; Mice, Inbred C57BL; NADPH Oxidase 4; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction | 2018 |
A new hypoglycemic mechanism of catalpol revealed by enhancing MyoD/MyoG-mediated myogenesis.
Topics: Animals; Blood Glucose; Cell Differentiation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Insulin Resistance; Iridoid Glucosides; Male; Mice; Mice, Inbred C57BL; Muscle Development; Muscle, Skeletal; MyoD Protein; Myogenin | 2018 |
Catalpol ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by suppressing the JNK and NF-κB pathways.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents; Diet, High-Fat; Gene Expression Regulation; Insulin Resistance; Iridoid Glucosides; Macrophages; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; NF-kappa B; Obesity; Panniculitis | 2015 |